Skip to main content
. 2016 Jun 17;14(2):1509–1514. doi: 10.3892/mmr.2016.5410

Figure 2.

Figure 2

CDKN3 expression is correlated with tumor stage. (A) CDKN3 expression at hepatocellular carcinoma tumor stages I-IV were determined using immunohistochemistry. (B) The association between CDKN3 expression and tumor stage was determined using logistic regression analysis. CDKN3, cyclin-dependent kinase inhibitor 3.